CTLA-4 promoter variants in patients with Graves' disease and Hashimoto's thyroiditis.
about
The CD40, CTLA-4, thyroglobulin, TSH receptor, and PTPN22 gene quintet and its contribution to thyroid autoimmunity: back to the futureGenetic analysis of the exon 1 position 49 CD152 dimorphism in multiple sclerosisGenetic evidence that the differential expression of the ligand-independent isoform of CTLA-4 is the molecular basis of the Idd5.1 type 1 diabetes region in nonobese diabetic mice.Hypothyroidism - new aspects of an old disease.Genetic susceptibility to autoimmune thyroid disease: past, present, and futureThe associations between the polymorphisms in the CTLA-4 gene and the risk of Graves' disease in the Chinese population.Association of Graves' disease and Graves' ophthalmopathy with the polymorphisms in promoter and exon 1 of cytotoxic T lymphocyte associated antigen-4 gene.The contribution of immune regulatory and thyroid specific genes to the etiology of Graves' and Hashimoto's diseases.Unravelling the genetic complexity of autoimmune thyroid disease: HLA, CTLA-4 and beyond.Immunogenetic mechanisms leading to thyroid autoimmunity: recent advances in identifying susceptibility genes and regions.Association of Cytotoxic T-Lymphocyte-Associated Protein 4 (CTLA4) Gene Polymorphisms with Autoimmune Thyroid Disease in Children and Adults: Case-Control Study.Immunogenetics of autoimmune thyroid diseases: A comprehensive review.Susceptibility to JRA/JIA: complementing general autoimmune and arthritis traits.Association between the CTLA-4 +49A/G polymorphism and Graves' disease: A meta-analysis.The etiology of autoimmune thyroid disease: a story of genes and environmentJoint genetic susceptibility to type 1 diabetes and autoimmune thyroiditis: from epidemiology to mechanisms.The role of genetics in Graves' disease and thyroid orbitopathy.Association between CTLA-4 gene promoter (49 A/G) in exon 1 polymorphisms and inflammatory bowel disease in the Tunisian population.Analysis of single nucleotide polymorphisms in the FAS and CTLA-4 genes of peripheral T-cell lymphomasDiagnosis of Hashimoto's thyroiditis and IgG4-related sclerosing disease.Linkage and association study of the CTLA-4 region in coeliac disease for Italian and Tunisian populations.The CTLA4 +49A/G polymorphism is associated with an increased risk of Hashimoto's thyroiditis in Asian but not Caucasian populations: an updated meta-analysis.Analysis of the CTLA-4, CD28, and inducible costimulator (ICOS) genes in autoimmune thyroid disease.Lack of association between cytotoxic T-lymphocyte antigen-4 -318C/T polymorphism and cancer risk: a meta-analysis of case-control studies.Cytotoxic T-lymphocyte associated antigen 4 polymorphism and Hashimoto's thyroiditis susceptibility: a meta-analysis.Evaluation of polymorphism, hypermethylation and expression pattern of CTLA4 gene in a sample of Iranian patients with schizophrenia.Polymorphism of the promoter region and exon 1 of the CTLA4 gene in endemic pemphigus foliaceus (fogo selvagem).CTLA-4 exon 1 +49A/G polymorphism is associated with renal involvement in pediatric Henoch-Schönlein purpuraNo evidence of association of CTLA-4 -318 C/T, 159 C/T, 3' STR and SUMO4 163 AG polymorphism with autoimmune diabetesThe CTLA4 region as a general autoimmunity factor: an extended pedigree provides evidence for synergy with the HLA locus in the etiology of type 1 diabetes mellitus, Hashimoto's thyroiditis and Graves' diseaseA CTLA-4 gene polymorphism at position -318 in the promoter region affects the expression of proteinRelation of three polymorphisms of the CTLA-4 gene in patients with Graves' disease
P2860
Q24673258-01EF6D95-B7AF-4C9E-9FDC-4EF5078BFE9DQ33614772-A2D9D051-7356-498D-89B4-AE2B5F29E0E7Q33854444-0333384A-40DE-4B85-9ECA-E0DE4260839AQ33953917-DB6EE01D-2B2C-4E17-918B-971F57EEE6DDQ34171280-08B0FDC5-10DC-4988-BF9C-DD36A1BD7D59Q34676633-7BCAC168-F0BD-4687-BE8A-14321BBAE760Q35129367-07B8F865-4D3B-4E64-B1E3-F701E4ACBF02Q35605705-8DEBCF8C-4E32-4421-9FAF-5808113E1CB4Q35696684-4834E276-83F0-473B-9E28-8C1E0124BB6AQ35730981-D949B22B-89AD-4599-A90B-52598E25B3C0Q35998164-A630FFF5-A496-45F5-BC24-8E7216F6FA6BQ36236762-71EC7ECD-F001-45ED-9AF2-ADCE9074BC87Q36376793-D55CFC5A-79A5-4775-A39B-104C4D32E5BCQ36416583-7398ABF9-869F-482E-A548-DED9744B1191Q36579326-44157919-3083-479B-8445-6A608341FD65Q36973929-DD30549C-DAF6-402F-B8DE-1ADBBD85DF03Q37063551-8514E459-C9CB-45E8-AE4B-6D05DCAAD0D1Q37243620-80F5C268-B1C7-4D38-9B39-551DE2DCBC07Q37266079-5308101F-AC48-4AE4-9C23-5FD397C6AD22Q37854859-F274B63C-B6DD-4856-9528-084EB387C81FQ38949041-B35ED265-3F79-4588-8E62-5B2910B03094Q44837632-098BA067-1E7C-49B5-8441-C601849B6C0AQ47349199-09A7E4A3-50BF-405C-B62E-38D8EFFC1A5CQ50928165-1E84C59A-CB55-491C-BAF3-8CC64332B235Q50991078-8A2D5ECF-A446-4CB1-A243-FB41A7E93969Q51000594-27FCD7A4-7F24-4D9B-A9EE-158168E114D7Q54581276-AB81CC23-DF71-42A9-A188-D766A8410473Q56897810-E1FE2733-2C77-40F7-9F10-B56BE7E3B664Q56901681-23A836B1-C000-432F-81AC-97DDFAF6FA56Q56904060-F98085D6-7FE8-4D4B-BE0B-8D9BA5966821Q56904398-6D3473FF-7DB5-4A5C-BCEC-21C31CEC991AQ56904580-0620C5B6-5409-4EA8-9803-DAC60955846E
P2860
CTLA-4 promoter variants in patients with Graves' disease and Hashimoto's thyroiditis.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh-hant
name
CTLA-4 promoter variants in patients with Graves' disease and Hashimoto's thyroiditis.
@en
CTLA-4 promoter variants in patients with Graves' disease and Hashimoto's thyroiditis.
@nl
type
label
CTLA-4 promoter variants in patients with Graves' disease and Hashimoto's thyroiditis.
@en
CTLA-4 promoter variants in patients with Graves' disease and Hashimoto's thyroiditis.
@nl
prefLabel
CTLA-4 promoter variants in patients with Graves' disease and Hashimoto's thyroiditis.
@en
CTLA-4 promoter variants in patients with Graves' disease and Hashimoto's thyroiditis.
@nl
P2093
P1433
P1476
CTLA-4 promoter variants in patients with Graves' disease and Hashimoto's thyroiditis.
@en
P2093
P304
P356
10.1111/J.1399-0039.1998.TB02993.X
P577
1998-05-01T00:00:00Z